Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces that its Chairman, DR, John Buchanan, has been awarded a knighthood by the Queen in Her Majesty's New Year Honours 2012. The award was given in recognition of Sir John's services to Industry.
Olivier Bohuon, Chief Executive Officer of Smith & Nephew, commented:
"Sir John has been the first to insist that the prestigious award is a reflection of the hard work and successes of the employees of Smith & Nephew. Anyone who has has the pleasure of working alongside him will, however, know this is richly deserved and a broader recognition of his leadership and track record in building successful global industrial enterprises. We are all delighted for Sir John and his family and I congratulate him on behalf of the whole of Smith & Nephew."
Sir John Joined the Board of smith & Nephew in 2005 and was appointed Chairman in April 2006. In addition, he is also Senior Independent director and Deputy Chairman of Vodafone Group, Senior Independent Director of BHP Billiton, Chairman of the International Chamber of Commerce (UK), Member of the Advisory Board of Ondra Bank and Chairman of UK Trustees for the Christchurch Earthquake Appeal. He is a former Executive Director and Group Financial Officer of BP, serving on the BP Board for six years.
Enquiries
| Investors | |
| Phil Cowdy | Tel: +44 (0) 20 7401 7646 |
| Smith & Nephew | |
| Media | |
| Charles Reynolds | Tel: +44 (0) 20 7401 7646 |
| Smith & Nephew | |
| Justine McIlroy | Tel: +44 (0) 20 7404 5959 |
| Brunswick - London |
About Smith & Nephew
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business or competitive nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.
Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.